BioSpace News Archive

Whole Exome Sequencing Market Size to Reach USD 4.2 billion by 2025 | Emergen Research

The global whole exome sequencing market size is expected to reach USD 4.2 billion by 2025 from USD 1.5 billion in 2020, at a CAGR of 25.1%.

September 22, 2022
·
7 min read
Business

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX) announced today that it has entered into a distribution agreement to market Monkeypox Virus Real-Time PCR Detection Kits with Cosmos Holdings Inc. (Nasdaq: COSM) (“Cosmos”).

September 22, 2022
·
4 min read
Biotech Beach

enVVeno Medical to Present at the Ladenburg Thalmann 2022 Healthcare Conference

enVVeno Medical Corporation today announced that Rob Berman, Chief Executive Officer of enVVeno Medical, will participate in a fireside chat at the Ladenburg Thalmann 2022 Healthcare Conference being held on September 29, 2022.

September 22, 2022
·
3 min read
Business

Curemark Announces the Key Addition of Dr. William R. McIntyre as Senior Vice President of Global Regulatory Affairs

Curemark announced the key addition of Dr. William R. McIntyre to the team as the Senior Vice President of Global Regulatory Affairs, effective immediately.

September 22, 2022
·
3 min read
Business

Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma and Fluidda

Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products (OINDPs), today announced an exclusive collaboration with Fluidda, a leader in the field of Functional Respiratory Imaging.

September 22, 2022
·
6 min read
Biotech Bay

FDA Grants QT Imaging™ Clearance to Calculate Fibroglandular Volume of the Breast

The U.S. Food and Drug Administration (FDA) has granted QT Imaging, Inc. 510(K) clearance to calculate the fibroglandular volume (FGV) of the breast and the ratio of FGV to total breast volume (TGV).

September 22, 2022
·
2 min read
Business

Dr. Sue Ellen Carpenter of INVO Bioscience’s Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly

INVO Bioscience, Inc. today announced that Dr. Sue Ellen Carpenter of Bloom Fertility, the Company’s Atlanta-based INVO Center, was named a recipient of the Castle Connolly Top Doctor Award for 2023.

September 22, 2022
·
5 min read
Business

Septerna Appoints Jeffrey Finer, MD, PhD, as Chief Executive Officer

Septerna, a biotechnology company discovering and advancing novel small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced that Jeffrey Finer, MD, PhD, has been named the company’s full-time Chief Executive Officer, transitioning from his current role as interim CEO.

September 22, 2022
·
3 min read
Global Prevalence of Chronic Kidney Diseases (CKD) is Expected to Drive the Hyperphosphatemia Treatment Market Revenue Growth by 2030 – Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Hyperphosphatemia Treatment Market – Forecast to 2030,’ thoroughly examines the Hyperphosphatemia Treatment industry to provide essential data & information for the targeted readers.

September 22, 2022
·
6 min read
Increasing Prevalence of Myofascial is Expected to Drive Myofascial Pain Syndrome Market Growth by 2030 – Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Myofascial Pain Syndrome Market – Forecast to 2030,’ thoroughly examines the Myofascial Pain Syndrome industry to provide essential data & information for the targeted readers.

September 22, 2022
·
6 min read